PubMed · 1983 · 76 citations · 8 references
MedicineImmunologyPathologyAutoimmunityImmunopathologyRenal PathophysiologyAutoantibodiesAutoimmune Disease PathogenesisAutoimmune DiseasesGlomerular DiseasesRenal DiseaseRenal ImmunopathologyAntibody Production ImpairmentAntibody-mediated Glomerular InjuryAutoimmune Glomerular DiseaseGlomerular AutoimmunityImmunofluorescence AssaysImmunofluorescence FindingsImmunofluorescence StainingImmunopathology Of Renal Disease
In this study we have evaluated the action of two compounds, cyclosporin A (Cy A) and thymulin (FTS-Zn) in old (NZB X NZW) F1 male mice which develop severe autoimmune disease. Compared with control mice, thymulin and Cy A treated mice already showed by 2 weeks a dramatic diminution of their anti-DNA antibody level which remained low throughout the treatment period and persisted for 7 weeks afterwards. Renal specimens were studied by direct immunofluorescence in Cy A and thymulin treated mice. Glomerular deposits were decreased compared with control mice; these differences were particularly clearcut for IgG1 and IgG2 deposits. Finally, thymulin (FTS-Zn) and Cy A appeared to induce the same improvement of DNA titres and glomerulopathy in (NZB X BW) F1 mice.
8
CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS
R. Y. Calne, S Thiru, P McMaster et al. · The Lancet · 1978 · 1K citations
Medicine, Nephrology, Surgery +10
Effects of the new anti-lymphocytic peptide cyclosporin A in animals.
J. F. Borel, Camille Feurer, C. Magnée et al. · PubMed · 1977 · 711 citations